Real-world patient outcomes on the efficacy of lanreotide treatment for neuroendocrine tumors: the influence of BMI, BSA and renal function
{{output}}
Background: Lanreotide is an effective and safe first-line therapy to treat patients with a gastro enteropancreatic (GEP) neuroendocrine tumor (NET). Precision oncology may be used to provide each patient with the right dosage. P... ...
